John Doscas insider trades: Chem Rx (CHRX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 23, 2008 | CHRX | ↓ Sell | 736,999 | $5.99 | $4.4M | Indirect | Jul 24, 2008 (1d) |
| Jul 22, 2008 | CHRX | ↓ Sell | 700,000 | $5.99 | $4.2M | Indirect | Jul 24, 2008 (2d) |
| Dec 3, 2007 | PMQC | ↓ Sell | 2,000 | $6.40 | $13K | Indirect | Dec 5, 2007 (2d) |
| Dec 3, 2007 | PMQC | ↓ Sell | 1,000 | $6.45 | $6K | Indirect | Dec 5, 2007 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About John Doscas's insider trades
John Doscas is a 10% owner of Chem Rx (CHRX). Since Dec 3, 2007, John has reported no open-market purchases and 4 sales worth $8.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CHRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.